Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Sep;35(9):1875–1878. doi: 10.1128/aac.35.9.1875

Comparative inactivation of isepamicin, amikacin, and gentamicin by nine beta-lactams and two beta-lactamase inhibitors, cilastatin and heparin.

J N Walterspiel 1, S Feldman 1, R Van 1, W R Ravis 1
PMCID: PMC245284  PMID: 1952861

Abstract

This study was undertaken to compare the susceptibility to inactivation of isepamicin with amikacin and gentamicin when exposed to different beta-lactams, beta-lactamase inhibitors, and heparin. The aminoglycosides (5, 10, 20, and 50 micrograms/ml) were incubated in human serum with ampicillin, azlocillin, aztreonam, carbenicillin, ceftazidime, piperacillin, and ticarcillin (100 and 600 micrograms/ml) and with clavulanate, cilastatin, 1:1 imipenemcilastatin, oxacillin, and sulbactam (20 and 120 micrograms/ml) for 48 h at 37 degrees C. Aminoglycoside concentrations were measured by fluorescence polarization immunoassay (FPI) after 0, 8, and 48 h of incubation and by radial diffusion bioassay after 48 h of incubation. Each of the three aminoglycosides was also added to whole blood containing either heparin (100 U/ml) or 0.5% EDTA as a control and assayed after 6 h by FPI. The degree of inactivation of isepamicin by the beta-lactams was significantly less than that by amikacin (P less than 0.003) and gentamicin (P less than 0.0002) when determined by bioassay. Piperacillin, carbenicillin, and azlocillin produced the greatest amount of inactivation, and cilastatin and oxacillin produced the least. A similar pattern was observed when the degree of inactivation was measured by FPI. A significant difference in the degree of inactivation was noted between isepamicin and gentamicin (P less than 0.003 at 8 h and P less than 0.006 at 48 h) but not between isepamicin and amikacin (P greater than 0.7 at 8 h and P greater than 0.08 at 48 h). Aminoglycoside determinations by FPI were not influenced by the presence of heparin. In summary, isepamicin was found to be at least as stable as amikacin against inactivation by beta-lactam compounds and beta-lactamase inhibitors. Heparin (100 U/ml) did not influence aminoglycoside determinations by FPI.

Full text

PDF
1875

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ebert S. C., Jorgensen J. H., Drutz D. J., Clementi W. A. Comparative assessment of in vitro inactivation of gentamicin in the presence of carbenicillin by three different gentamicin assay methods. J Clin Microbiol. 1984 Oct;20(4):701–705. doi: 10.1128/jcm.20.4.701-705.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ervin F. R., Bullock W. E., Jr, Nuttall C. E. Inactivation of gentamicin by penicillins in patients with renal failure. Antimicrob Agents Chemother. 1976 Jun;9(6):1004–1011. doi: 10.1128/aac.9.6.1004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Fuchs P. C., Stickel S., Anderson P. H., Barry A. L., Shilling S. In vitro inactivation of aminoglycosides by sulbactam, other beta-lactams, and sulbactam-beta-lactam combinations. Antimicrob Agents Chemother. 1991 Jan;35(1):182–184. doi: 10.1128/aac.35.1.182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Glew R. H., Pavuk R. A. Stability of gentamicin, tobramycin, and amikacin in combination with four beta-lactam antibiotics. Antimicrob Agents Chemother. 1983 Oct;24(4):474–477. doi: 10.1128/aac.24.4.474. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Henderson J. L., Polk R. E., Kline B. J. In vitro inactivation of gentamicin, tobramycin, and netilmicin by carbenicillin, azlocillin, or mezlocillin. Am J Hosp Pharm. 1981 Aug;38(8):1167–1170. [PubMed] [Google Scholar]
  6. Holt H. A., Broughall J. M., McCarthy M., Reeves D. S. Interactions between aminoglycoside antibiotics and carbenicillin or ticarillin. Infection. 1976;4(2):107–109. doi: 10.1007/BF01638726. [DOI] [PubMed] [Google Scholar]
  7. Katsu M., Saito A. [New antimicrobial agents series XXXIV: isepamicin]. Jpn J Antibiot. 1989 Mar;42(3):543–566. [PubMed] [Google Scholar]
  8. McLaughlin J. E., Reeves D. S. Clinical and laboratory evidence for inactivation of gentamicin by carbenicillin. Lancet. 1971 Feb 6;1(7693):261–264. doi: 10.1016/s0140-6736(71)91001-4. [DOI] [PubMed] [Google Scholar]
  9. Nilsson L., Maller R., Anséhn S. Inhibition of aminoglycoside activity in heparin. Antimicrob Agents Chemother. 1981 Aug;20(2):155–158. doi: 10.1128/aac.20.2.155. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Pickering L. K., Gearhart P. Effect of time and concentration upon interaction between gentamicin, tobramycin, Netilmicin, or amikacin and carbenicillin or ticarcillin. Antimicrob Agents Chemother. 1979 Apr;15(4):592–596. doi: 10.1128/aac.15.4.592. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pickering L. K., Rutherford I. Effect of concentration and time upon inactivation of tobramycin, gentamicin, netilmicin and amikacin by azlocillin, carbenicillin, mecillinam, mezlocillin and piperacillin. J Pharmacol Exp Ther. 1981 May;217(2):345–349. [PubMed] [Google Scholar]
  12. Riff L. J., Thomason J. L. Comparative aminoglycoside inactivation by beta-lactam antibiotics. Effects of a cephalosporin and six penicillins on five aminoglycosides. J Antibiot (Tokyo) 1982 Jul;35(7):850–857. doi: 10.7164/antibiotics.35.850. [DOI] [PubMed] [Google Scholar]
  13. Schentag J. J., Simons G. W., Schultz R. W., Vance J. W., Williams J. S. Complexation versus hemodialysis to reduce elevated aminoglycoside serum concentrations. Pharmacotherapy. 1984 Nov-Dec;4(6):374–380. doi: 10.1002/j.1875-9114.1984.tb03399.x. [DOI] [PubMed] [Google Scholar]
  14. Slocombe B., Sutherland R. Transferable antibiotic resistance in enteropathogenic Escherichia coli between 1948 and 1968. Antimicrob Agents Chemother. 1973 Oct;4(4):459–466. doi: 10.1128/aac.4.4.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tindula R. J., Ambrose P. J., Harralson A. F. Aminoglycoside inactivation by penicillins and cephalosporins and its impact on drug-level monitoring. Drug Intell Clin Pharm. 1983 Dec;17(12):906–908. doi: 10.1177/106002808301701210. [DOI] [PubMed] [Google Scholar]
  16. Uematsu T., Mizuno A., Suzuki Y., Sato R., Yamazaki T., Nakashima M. Evaluation of a fluorescence polarization immunoassay procedure for quantitation of isepamicin, a new aminoglycoside antibiotic. Ther Drug Monit. 1988;10(4):459–462. doi: 10.1097/00007691-198804000-00014. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES